No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
REIT - Healthcare Facilities
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
www.plifereit.comNo one on the platform currently holds C2PU.SI.
No tracked institution reports a position in C2PU.SI as of their last filing.
No one on the platform has traded C2PU.SI yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 5.0% | 4.7% | 5.6% | — | — | — |
| Rev. Growth % | 13.9% | 6.4% | ||||
| Profit Margin % | 92.6% | 106.6% | 102.3% | |||
| Free Cash Flow Margin % | 0.0% | 34.7% | 52.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $167M | +4.4% | $0.18 | $0.17–$0.19 | — | 4 |
| 2027 | $169M | +1.7% | $0.18 | $0.17–$0.20 | — | 4 |
| 2028 | $172M | +1.4% | $0.19 | $0.18–$0.21 | — | 3 |
| 2029 | $263M | +52.9% | $0.06 | $0.05–$0.07 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| $0.82 |
| +0.61% |
| $3.2B |
| — |
| JYEU.SILendlease Global Commercial REIT | $0.55 | +0.00% | $1.2B | — |
| K71U.SIKeppel REIT | $0.84 | -0.59% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry